期刊文献+

阿莫西林、呋喃唑酮、雷贝拉唑和铋剂联用治疗幽门螺杆菌感染致急性肾损伤 被引量:8

Acute kidney injury due to combination therapy with amoxicillin,furazolidone,rabeprazole,and bismuth for Helicobacter pylori infection
原文传递
导出
摘要 1例58岁男性患者接受四联疗法治疗幽门螺杆菌感染,给药方案为口服阿莫西林(1 g,2次/d)、呋喃唑酮(0.1 g,2次/d)、雷贝拉唑(20 mg、2次/d)和枸橼酸铋钾(0.6 g、2次/d),共用药4周。停药7 d后实验室检查示血肌酐(Scr)469μmol/L,尿素氮(BUN)19.2 mmol/L;肾组织活检病理检测结果提示急性肾小管损伤。患者半年前体检结果显示Scr 78μmo/L。考虑患者的急性肾损伤与四联疗法有关。给予甲泼尼龙、瑞巴派特和碳酸钙口服。4周后复查,Scr 171μmol/L,BUN 14.4 mmol/L,继续上述治疗;12周后复查,Scr 140μmol/L,BUN 11.4 mmol/L。 A 58⁃year⁃old male patient received quadruple therapy with amoxicillin 1 g,furazo⁃lidone 0.1 g,rabeprazole 20 mg,and bismuth potassium citrate 0.6 g twice daily for Helicobacter pylori infec⁃tion for 4 weeks.Seven days after drug withdrawal,the laboratory tests showed serum creatinine(Scr)469μmol/L and blood urea nitrogen(BUN)19.2 mmol/L.Renal biopsy showed acute tubular injury.The Scr level was 78μmol/L in the physical examination of 6 months ago.Acute kidney injury was considered to be associated with the quadruple therapy.Methylprednisolone,rebamipide,and calcium carbonate were given orally.Four weeks later,the laboratory tests showed Scr 171μmol/L and BUN 14.4 mmol/L and the above treatments were continued;12 weeks later,his Scr was 140μmol/L and BUN was 11.4 mmol/L.
作者 吴淑娟 顾尔敏 叶晓兰 Wu Shujuan;Gu Ermin;Ye Xiaolan(Department of Pharmacy,Ruian People′s Hospital,the Third Affiliated Hospital of Wenzhou Medical University,Zhejiang Province,Wenzhou 325200,China;Department of Pharmacy,the First People′s Hospital of Jiashan,Zhejiang Province,Jiaxing 314100,China;Department of Pharmacy,Zhejiang Provincial People′s Hospital,People′s Hospital of Hangzhou Medical College,Hangzhou 310014,China)
出处 《药物不良反应杂志》 CSCD 2021年第1期45-46,共2页 Adverse Drug Reactions Journal
关键词 阿莫西林 呋喃唑酮 雷贝拉唑 铋剂 螺杆菌 幽门 急性肾损伤 Amoxicillin Rabeprazole Furazolidone Bismuth Helicobacter pylori Acute kidney injury
  • 相关文献

参考文献4

二级参考文献40

  • 1张晓东,方敬爱,武明虎.奥美拉唑导致间质性肾炎的临床分析[J].中国中西医结合肾病杂志,2006,7(9):543-543. 被引量:19
  • 2边晓慧,纪镇华,王艳秋,李德天.药物致急性间质性肾炎19例分析[J].实用药物与临床,2007,10(2):109-110. 被引量:3
  • 3陈灏珠.实用内科学[M].12版.北京:人民卫生出版社,2006:2582
  • 4Praga M, Sevillano A, Aufien P, et al. Changes in the aetiology, chnical presentation and management of acute interstitial nephri- tis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant,2015,30(9) :1472 -1479.
  • 5Klepser DG, Collier DS, Cochran GL. Proton pump inhibitors and acute kidney injury : a nested case - control study. BMC Nephrol, 2013,14(1) :150.
  • 6Leonard CE, Freeman CP, Newcomb CW, et al. Proton pump in- hibitors and traditional nonsteroidal anti - inflammatory drugs and the risk of acute interstitial nephritis and acute kidney inju- ry. Pharmacoepidemiol Drug Saf,2012,21 ( 11 ) : 1155 - 1172.
  • 7Blank ML, Parkin L, Paul C, et al. A nationwide nested case - control study indicates an increased risk of acute interstitial ne- phritis with proton pump inhibitor use. Kidney Int,2014,86(4) : 837 - 844.
  • 8Valluri A, Hetherington L, Mcquarrie E, et al. Acute tubulointer- stitial nephritis in Scotland. QJM ,2015,108 (7) :527 - 532.
  • 9Muriithi AK, Leung N, Valeri AM, et al. Biopsy - Proven Acute Interstitial Nephritis, 1993 - 2011 : A Case Series. Am J Kidney Dis ,2014,64 (4) :558 - 566.
  • 10Goicoechea M, Rivera F, Lepez - Gemez JM, et al. Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant,2013,28( 1 ) :112 - 115.

共引文献13

同被引文献65

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部